Q3 2019 Matinas BioPharma Holdings Inc Earnings Call Transcript
Greetings and welcome to the Matinas BioPharma Third Quarter 2019 Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Peter Vozzo, Investor Relations representative for Matinas BioPharma. Please go ahead, sir.
Thank you, Kevin. Good morning, everyone, and thank you for joining the Matinas BioPharma Third Quarter 2019 Results Conference Call.
Earlier this morning, we issued a press release with our third quarter 2019 financial results along with business updates. The release is available on the Matinas BioPharma website under the Investors section.
Speaking on today's call will be Jerry Jabbour, Chief Executive Officer, who will discuss the company's corporate progress and key milestones; Keith Kucinski, Chief Financial Officer, will then review third quarter financial results. We also have Dr. Terry Ferguson, Chief Medical Officer; and Dr. Terri Matkovits, Chief Development Officer, who will be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
